Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.61 USD | 0.00% | +10.06% | +572.25% |
May. 14 | Stephens Starts Elevation Oncology With Overweight Rating, $8 Price Target | MT |
May. 02 | Elevation Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Chart calendar Elevation Oncology, Inc.
Upcoming events on Elevation Oncology, Inc.
Past events on Elevation Oncology, Inc.
2024-05-14 11:30 am | Citizens JMP Life Sciences Conference |
2024-05-02 07:30 am | Q1 2024 Earnings Release |
2024-04-08 04:30 pm | American Association for Cancer Research Meeting - Abstract: #3121 |
2024-03-11 | Leerink Partners Global Biopharma Conference |
2024-03-06 10:30 am | TD Cowen Health Care Conference |
2023-11-29 08:30 am | Piper Sandler Healthcare Conference |
2023-11-02 07:30 am | Q3 2023 Earnings Release |
2023-08-03 07:30 am | Q2 2023 Earnings Release |
2023-06-16 11:00 am | Annual General Meeting |
2023-06-03 01:15 pm | American Society of Clinical Oncology Conference - Abstract # 3016 Poster # 214 |
2023-06-01 | American Society of Clinical Oncology Conference |
2023-05-15 07:30 am | Q1 2023 Earnings Release |
2023-04-19 09:00 am | American Association for Cancer Research Meeting - Abstract Number: 6300 |
2023-04-18 09:00 am | American Association for Cancer Research Meeting - Abstract Number: CT229 |
2023-04-17 10:15 am | American Association for Cancer Research Meeting |
2023-04-16 01:30 pm | American Association for Cancer Research Meeting - Abstract Number: 921 |
2023-03-15 08:00 am | Oppenheimer Healthcare Conference |
2023-03-09 07:30 am | Q4 2022 Earnings Release |
2023-03-07 12:50 pm | Cowen Health Care Conference |
2023-02-15 04:20 pm | SVB Securities Global Biopharma Conference |
Annual results
Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBITDA Million USD | Released Forecast Spread | 0,00 | -32,0 -37,2 13.84% | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBIT Million USD | Released Forecast Spread | 0,00 | -32,0 -35,9 10.71% | -94,5 -97,1 2.62% | -40,3 -48,9 17.59% | -44,6 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -32,0 -36,1 11.29% | -95,1 -97,0 2.02% | -45,7 -49,3 7.34% | -46,5 |
Net income Million USD | Released Forecast Spread | -17,3 | -32,0 -36,4 12% | -95,1 -94,3 -0.78% | -45,7 -49,3 7.37% | -48,1 |
EPS USD | Released Forecast Spread | -21,8 | -2,64 -2,69 1.79% | -4,09 -3,95 -3.63% | -1,34 -1,46 8.22% | -0,93 |
Announcement Date | 04/06/21 | 03/03/22 | 09/03/23 | 06/03/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
EBITDA Million USD | Released Forecast Spread | -17,4 -11,0 -57.85% | -20,1 -18,0 -11.71% | -38,5 -21,0 -83.44% | |||||||||||
EBIT Million USD | Released Forecast Spread | -17,4 -12,2 -42.31% | -20,1 -18,3 -9.9% | -38,5 -38,6 0.19% | -18,5 -21,1 12.1% | -16,7 -15,5 -7.69% | -9,83 -11,4 13.45% | -10,9 -11,2 2.19% | -7,95 -11,4 30.59% | -9,87 -9,57 -3.18% | -10,8 | -11,6 | -12,3 | ||
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -17,3 -12,9 -33.6% | -19,9 -18,2 -9.29% | -38,8 -38,5 -0.77% | -19,0 -21,0 9.42% | -17,1 -15,8 -8.06% | -10,1 -12,1 16.2% | -10,6 -11,5 7.41% | -7,89 -11,4 30.99% | -10,7 -9,55 -12.05% | -11,2 | -11,9 | -12,7 | ||
Net income Million USD | Released Forecast Spread | -17,3 -12,2 -41.33% | -19,9 -18,2 -9.34% | -38,8 -34,3 -13.38% | -19,0 -18,3 -3.88% | -17,1 -14,1 -21.09% | -10,1 -11,9 15.25% | -10,6 -11,2 5.3% | -7,90 -11,5 31.23% | -10,7 -9,98 -7.24% | -11,5 | -12,3 | -13,3 | ||
EPS USD | Released Forecast Spread | -0,74 -0,53 -40.28% | -0,86 -0,79 -9.15% | -1,67 -1,30 -28.74% | -0,82 -0,73 -11.95% | -0,72 -0,59 -21.35% | -0,37 -0,28 -34.55% | -0,25 -0,32 21.88% | -0,19 -0,24 20.17% | -0,23 -0,20 -13.86% | -0,23 | -0,23 | -0,24 | -0,21 | -0,22 |
Announcement Date | 05/05/22 | 04/08/22 | 03/11/22 | 09/03/23 | 15/05/23 | 03/08/23 | 02/11/23 | 06/03/24 | 02/05/24 | - | - | - | - | - |
Past sector events for Elevation Oncology, Inc.
2024-05-17 07:00 am | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
2024-05-16 07:46 am | BIOCON LIMITED: Q4 2024 Earnings Release |
2024-05-16 01:00 am | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
2024-05-15 08:05 am | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
2024-05-15 07:00 am | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
2024-05-14 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
2024-05-15 04:01 pm | CELCUITY INC.: Q1 2024 Earnings Release |
2024-05-14 04:05 pm | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 04:00 pm | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 08:00 am | IMMUNOME, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ELEV Stock
- Calendar Elevation Oncology, Inc.